Askari Townshend

Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ.

The Waste & Resources Action Programme provides environmental protection services. The firm helps to businesses and individuals reap the benefits of reducing waste, develop sustainable products and use resources in an efficient way. The company was founded in 2000 and is headquartered in Oxfordshire, United Kingdom.

Part of Elliott International Advisors GP LLC, Continuing Medical Education, Inc. publishes medical magazines and journals. The company is based in San Diego, CA. Continuing Medical Education was acquired by Miller Freeman, Inc., part of Elliott International Advisors GP LLC from July 18, 2000 on March 26, 1999 for $111 million.

The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research.

American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA.

The International Women's Health Coalition is a non-profit organization that works to advance the sexual and reproductive health and rights of women and girls. The non-profit company is based in New York, NY.

The American Society for Aesthetic Plastic Surgery operates an association for plastic surgeons. The non-profit company is based in Los Alamitos, CA. Mark Theis has been the CEO of the company since 2023.

Sheffield Teaching Hospitals NHS Foundation Trust operates various adult hospitals. It offers local hospital services in Sheffield as well as specialist services to patients from further field. The firm's services include treatments in the fields of neurosciences, spinal injuries, cancer, transplantation, neurosciences, and orthopaedics. The company was founded in July 2004 and is headquartered in Sheffield, the United Kingdom.

Anglo American South Africa Ltd. engages in the exploration and mining of precious, base, and ferrous metals. It produces and markets platinum, thermal coal, diamonds and iron ore. The company was founded in 1917 and is headquartered in Johannesburg, South Africa.

Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom.

Part of Johnson & Johnson, Janssen Research & Development LLC is a company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ.

The Ombudsman Service Ltd. is a non-profit company based in the UK that helps consumers and businesses settle disputes with communications or energy companies in a fair manner. The British company has subsidiaries in the United Kingdom. The company was founded in 2002 and Matthew Vickers has been the CEO since 2015.

Republic Healthcare Holdings Pte Ltd. functions as an investment holding Singaporean company. The company is based in Singapore, Singapore.

Brunel Clinics Pte Ltd. operates medical clinics. The private company is based in Singapore, Singapore.

Republic Healthcare Pte Ltd. provides healthcare services. The private company is based in Singapore, Singapore.

Cher Sen Holdings Ltd. functions as an investment holding There is no available country named vg company. The company is based in Road Town, British Virgin Islands.

Rothamsted Enterprises Ltd. operates a conference center. The joint venture company is based in Harpenden, UK. The British company was founded in 1999. The CEO is Nicole Sadd.

Engitix Ltd. is a preclinical stage biopharma British company that is developing breakthrough therapies for fibrosis and solid tumors using its patient-centric human extracellular matrix drug discovery platform. The company has drug discovery partnerships with Dompe Farmaceutici and Takeda for advanced fibrotic liver diseases and fibrostenotic inflammatory bowel disease. Engitix was established in 2016 to commercialize research from the Institute for Liver and Digestive Health at University College London. The company is headquartered in WestWorks, London, UK. Giuseppe Mazza and Massimo Pinzani founded the company, and Giuseppe Mazza has been the CEO since 2016.

Ichnos Sciences, Inc. operates as a biotechnology company. It provides curative therapies that extend human life. The company was founded in 2019 and is headquartered in Paramus, NJ.

Georgiamune, Inc. is a clinical stage biotechnology company that focuses on reprogramming immune signaling pathways to redirect the immune system to fight diseases. The company is based in Silver Spring, MD. The company has designed unique approaches to re-establish immune balance, and its scientific discoveries have led to pioneering immunotherapies targeting high unmet needs. Georgiamune's lead program, Gim-122, is a first-in-class, dual-functioning monoclonal antibody designed to overcome immune therapy resistance in cancer patients. In addition to its lead program, the company is advancing a pipeline of first-in-class therapies for cancer and autoimmune diseases. The company was founded by Samir N. Khleif, a world-renowned medical oncologist and researcher in the field of immunology and cancer, based on discoveries in his lab on novel mechanisms to modulate immune response. Samir N. Khleif has been the CEO since incorporation.